NCT04933188

Brief Summary

This prospective study intends to explore the change of cardiac structure and function in the cohort of overweight or obesity patients, and determine the impact of clinical characteristics on cardiac remodeling and mechanics.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2019

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

March 30, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 21, 2021

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 18, 2024

Status Verified

March 1, 2024

Enrollment Period

5.7 years

First QC Date

March 30, 2021

Last Update Submit

March 14, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • investigate the change of global myocardial work index (GWI) in overweight or obese patients

    GWI derived from echocardiography will be assessed in overweight or obese patients and compare with lean controls

    within 24 hours of the recruitment

  • investigate the change of global constructive work (GCW) in overweight or obese patients

    GCW will be assessed in overweight or obese patients and compare with lean controls

    within 24 hours of the recruitment

  • investigate the change of global waste work (GWW) in overweight or obese patients

    GWW will be assessed in overweight or obese patients and compare with lean controls

    within 24 hours of the recruitment

  • investigate the change of global work efficiency (GWE) in overweight or obese patients

    GWE will be assessed in overweight or obese patients and compare with lean controls

    within 24 hours of the recruitment

Study Arms (3)

control

Lean health controls with a BMI\<25kg/m2

Diagnostic Test: Myocardial work was estimated from left ventricular pressure-strain loop derived from speckle tracking echocardiography and non-invasive brachial artery cuff pressure

overweight

patients with a BMI of 25-30kg/m2

Diagnostic Test: Myocardial work was estimated from left ventricular pressure-strain loop derived from speckle tracking echocardiography and non-invasive brachial artery cuff pressure

obesity

patients with a BMI of over 30kg/m2

Diagnostic Test: Myocardial work was estimated from left ventricular pressure-strain loop derived from speckle tracking echocardiography and non-invasive brachial artery cuff pressure

Interventions

Baseline and follow-up examination of echocardiography is to be performed on study subjects.

controlobesityoverweight

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

overweight or obese subjects referred to the endocrinology inpatients

You may qualify if:

  • All patients were older than 18 without any cardiac symptoms.
  • The diagnosis of overweight was established when body mass index (BMI) of 25 to 30 kg/m2.
  • Obese was defined as a BMI of 30 kg/m2 or higher.

You may not qualify if:

  • diagnosis of type 2-Diabetes Mellitus according to the American Diabetes Association criteria;
  • left ventricular ejection fraction\<50% on echocardiography;
  • arrythmia on electrocardiogram;
  • severe valvular stenosis or regurgitation;
  • history of coronary disease (defined as stenosis\>50%) or myocardial infarction;
  • stress induced wall motion abnormality on echocardiography, coronary artery stenosis \>50% on coronary CT or angiography with Framingham risk score of \>10;
  • pacemaker or defibrillator implantation;
  • the presence of bundle branch block;
  • severe infection or renal dysfunction with an estimated glomerular filtration rate \< 60 ml/min/1.73 m2);
  • inadequate image quality on echocardiography.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renji Hospital

Shanghai, Shanghai Municipality, 200127, China

RECRUITING

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Meng Jiang

    RenJi Hospital

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2021

First Posted

June 21, 2021

Study Start

May 1, 2019

Primary Completion

December 30, 2024

Study Completion

December 31, 2024

Last Updated

March 18, 2024

Record last verified: 2024-03

Locations